|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001554,
umls-concept:C0006826,
umls-concept:C0018787,
umls-concept:C0030705,
umls-concept:C0036043,
umls-concept:C0205480,
umls-concept:C0439590,
umls-concept:C1511572,
umls-concept:C1522690,
umls-concept:C1979963,
umls-concept:C2003903
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2004-7-20
|
|
pubmed:abstractText |
Pegylated liposomal doxorubicin (PLD) is currently utilized in the management of several solid tumors. While PLD has been shown to be less cardiotoxic than doxorubicin, the safety of prolonged administration (e.g., >or=6 cycles) of the agent remains undefined.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0090-8258
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
94
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
147-51
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:15262133-Aged,
pubmed-meshheading:15262133-Aged, 80 and over,
pubmed-meshheading:15262133-Antibiotics, Antineoplastic,
pubmed-meshheading:15262133-Dose-Response Relationship, Drug,
pubmed-meshheading:15262133-Doxorubicin,
pubmed-meshheading:15262133-Drug Administration Schedule,
pubmed-meshheading:15262133-Endometrial Neoplasms,
pubmed-meshheading:15262133-Female,
pubmed-meshheading:15262133-Gated Blood-Pool Imaging,
pubmed-meshheading:15262133-Heart Diseases,
pubmed-meshheading:15262133-Humans,
pubmed-meshheading:15262133-Middle Aged,
pubmed-meshheading:15262133-Ovarian Neoplasms,
pubmed-meshheading:15262133-Peritoneal Neoplasms,
pubmed-meshheading:15262133-Retrospective Studies,
pubmed-meshheading:15262133-Ventricular Function, Left
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Cardiac safety profile of prolonged (>or=6 cycles) pegylated liposomal doxorubicin administration in patients with gynecologic malignancies.
|
|
pubmed:affiliation |
Department of Gynecology/Obstetrics and Hematology/Medical Oncology, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA. uyard@ccf.org
|
|
pubmed:publicationType |
Journal Article
|
